Putnam Investments LLC Catalyst Pharmaceuticals, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 26,498 shares of CPRX stock, worth $538,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,498
Previous 29,983
11.62%
Holding current value
$538,969
Previous $350,000
27.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
102MCall Options Held
15.8KPut Options Held
234K-
Black Rock Inc. New York, NY18.7MShares$380 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$111 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.1 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...